Singapore’s KPB Biosciences fails in bid to unfreeze assets in US$830 million Novo Nordisk legal battle
Locally headquartered biotech firm KPB Biosciences has failed to set aside a court order for its assets to be frozen, ...
Locally headquartered biotech firm KPB Biosciences has failed to set aside a court order for its assets to be frozen, ...
The NY Journals pride themselves on assembling a proficient and dedicated team comprising seasoned journalists and editors. This collective commitment drives us to provide our esteemed readership with nothing short of the most comprehensive, accurate, and captivating news coverage available.
Transcending the bounds of New York City to encompass a broader scope, we ensure that our audience remains well-informed and engaged with the latest developments, both locally and beyond.
© 2026 The New York Journals. All Rights Reserved.